期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

抗VEGF药物Avastin治疗眼后段新生血管性眼病研究进展 被引量：9

Make Drogress of Study Treat of ocular Neovascular Disease on Avastin
下载PDF
导出
摘要 眼部新生血管性疾病特别是眼后段的新生血管可以导致多种眼部疾病,眼内的新生血管的形成与血管内皮生长因子(VEGF)有关。目前抗VEGF的药物逐渐开始在眼科应用。其中的代表药物有Avastin、Lusentis等。本研究对VEGF在眼部新生血管形成中的作用,以及Avastin的作用机制、眼部适应症和副作用进行综述。 Ocular neovascular diseases,especially posterior segment neovascularization,relate vascular endothelial growth factor（VEGF）.Therefore, anti-VEGF drugs are used in eye diseases step by step,Including representatives of drugs Avastin.In this article,it is summarized that the characteristics and angiogenesis of VEGF in neovasctdar disease of eyeball and the mechanism of Avastin in the posterior section of scope of application and side effects.
作者 李琳 朱丹
机构地区 内蒙古医学院附属医院眼科
出处 《疾病监测与控制》 2010年第4期198-201,共4页 Journal of Diseases Monitor and Control
关键词 AVASTIN VEGF 眼部新生血管性疾病 Avastin VEGF ocular neovascular disease
分类号 R771 [医药卫生—眼科]
  • 相关文献

参考文献54

  • 1李凤鸣,主编.眼科全书[M].第二版,北京:人民卫生出版社,2005,2227.
  • 2Yancopoulos GD,Davis S,Gale NW, et al.Vascular-specific growth factors and blood vessel formation. Nature,2000,407(14):242 - 248.
  • 3Meyer-Schwickerath R,Pfeiffer A,Blum WF,Freyberger H,Klein M,Loscbe C,et al.Vitreous levels of the insulin-like growth factors Ⅰ and Ⅱ, the insulin-like growth factor binding proteins 2 and 3 increase in neovaseular eye disease.Clin Invest, 1993,92:2620-2625.
  • 4Yancopoulos GD,Davis S,Gale NW,et al.Vascular-specific growlh factors and blood vessel formation.Nature,2000,407(14):242-248.
  • 5周洪伟,吴强.血管内皮生长因子及其受体与眼底新生血管[J].国际眼科杂志,2007,7(3):791-795. 被引量：17
  • 6Tolentino MJ, Miller JW,Gragoudas ES,et al.lntravitreous injection of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate.Ophthalmology, 1996,103( 11): 1820-1828.
  • 7Tolentino MJ,McLeod DS,Taomoto M,et al. Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate.Am J Ophthalmol,2002,133(3):373-385.
  • 8Senger DR,Galli SJ, Dvorak AM,et al.Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science, 1983,219(4587):983 -985.
  • 9Leung DW,Caehianes G,et al.Vascular endothelial growth factor is a secreted angiogenic mitogen.Science, 1989,246(4935): 1306 - 1309.
  • 10Cross MJ,Claeason-Welsh L.FGF and VEGF function in angiogenesis:signalling pathways,biological responses and therapeutic inhibition. Trends Pharmacol Sci,2001,22(4):201 -207.

二级参考文献53

  • 1胡春玲,陈维,惠延年.早期糖尿病大鼠视网膜中MMP-3和VEGF表达的意义[J].国际眼科杂志,2004,4(4):615-617. 被引量：10
  • 2刘庆淮,谢平,戈应宾,袁孝如.糖尿病患者眼前房液血管内皮生长因子与转化生长因子β_2的变化[J].国际眼科杂志,2004,4(6):1015-1018. 被引量：9
  • 3蔡春梅,孙葆忱,刘旭阳.短发夹RNA对人视网膜色素上皮细胞血管内皮生长因子表达的抑制[J].中华眼科杂志,2006,42(4):334-337. 被引量：6
  • 4许建华,刘哲丽,李若溪,孔伟,张薇.曲安奈德对缺氧条件下恒河猴脉络膜视网膜内皮细胞VEGF表达的影响[J].国际眼科杂志,2006,6(5):1053-1055. 被引量：9
  • 5Singh N,Amin S,Richter E,Rashid S,Scoglietti V,Jani PD,Wang J,Kaur R,Ambati J,Dong Z,Ambati BK.Flt-1 Intraceptors Inhibit Hypoxia-Induced VEGF Expression In Vitro and Corneal Neovascularization In Vivo.Invest Ophthalmol Vis Sci,2005;46:1647-1652
  • 6Ideno J,Mizukami H,Kakehashi A.Prevention of diabetic retinopathy by intraocular soluble flt-1 gene transfer in a spontaneously diabetic rat model.Int J Mol Med,2007; 19(1):75-79
  • 7VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group; D'Amico DJ,Masonson HN,Patel M,Adamis AP,Cunningham ET Jr,Guyer DR,Katz B.Pegaptanib sodium for neovascular age-related macular degeneration:two-year safety results of the two prospective,multicenter,controlled clinical trials.Ophthalmology,2006;113(6):992-1001
  • 8Adamis AP,Altaweel M,Bressler NM,Cunningham ET Jr,Davis MD,Goldbaum M,Gonzales C,Guyer DR,Barrett K,Patel M; Macugen Diabetic Retinopathy Study Group.Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals.Ophthalmology,2006;113(1):23-28
  • 9Robinson GS,Pierce EA,Rook SL,Foley E,Webb R,Smith LE.Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy.Proc Natl Acad Sci USA,1996;93(10):4851-4856
  • 10Lai CM,Spilsbury K,Brankov M,Zaknich T,Rakoczy PE.Inhibition of corneal neovascularization by recombinant adenovirus mediated antisense VEGF RNA.Exp Eye Res,2002;75 (6):625 -634

共引文献16

同被引文献80

  • 1汤洋,唐罗生.老年黄斑变性的治疗研究进展[J].国际眼科杂志,2006,6(6):1393-1396. 被引量：13
  • 2邵彦,李筱荣.抗血管内皮生长因子药物治疗年龄相关性黄斑变性的现状[J].眼科,2007,16(4):282-284. 被引量：10
  • 3Hurwitz H ,renbaeher L, Novotny W, et al. Bevacizumab plus irinotecan,fluorouracil,and leueovorin for metastatic colorectal cancer [ J]. N Engl J Med,2004,350:2335 - 2342.
  • 4Robert L. Avery, Dante J, et al. Intravitreal Bevacizumab for Neovas- cular Age - Related Macular Degeneration [ J ]. Ophthalmol, 2006, 113:363 - 372.
  • 5Davidorff H, Mouser JG, Derrick RJ. Rapid improvement of rubeosis iridis from asingle bevacizumab injection[ J]. Retina,2006,26 (3) : 354 -356.
  • 6Fung AE, Rosenfeld PJ, Reichel E. The international intravitreal bevacizumab, safety survery: using the intemet to assess drug safety world - wide[ J]. Ophthalmol,2006,90( 11 ) : 1344 - 1349.
  • 7Watzke RC, Packer A J, Folk JC, et al. Punctuate choroidopathy. Am J Ophthalmol,1984,98:572-584.
  • 8Folk JC, Walker JD. Multifocal choroiditis with panuveitis, diffuse subretinal fibrosis and punctuate inner choroidopathy// Retina. 4th ed. St.Louis: Mosby Inc.,2006:1771-1783.
  • 9Amer R, Lois N. Punctuate inner choroidopathy. Surv Ophthalmol, 2011,56 : 36-53.
  • 10Becker KG. The common genetic hypothesis of autoimmune/ inflammatory disease. Curt Opin Allergy Clin Immunol,2001, 1 : 399-405.

引证文献9

二级引证文献47

疾病监测与控制
2010年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部